Diabetes but not insulin is associated with higher colon cancer mortality

被引:10
|
作者
Tseng, Chin-Hsiao [1 ,2 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Div Endocrinol & Metab, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei 100, Taiwan
关键词
Colon cancer; Diabetes mellitus; Mortality; Secular trend; SPORADIC COLORECTAL-CANCER; METABOLIC SYNDROME; RISK-FACTORS; MELLITUS; TAIWAN; SURVIVAL; DISEASE; THERAPY; SMOKING; GLUCOSE;
D O I
10.3748/wjg.v18.i31.4182
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To evaluate whether diabetic patients had a higher risk of colon cancer mortality and its associated risk factors. METHODS: The sex-specific crude and age-standardized (to the 2000 World Health Organization population) mortality rates of colon cancer in the Taiwanese general population were first calculated from 1995 to 2006. The trends were evaluated by linear regression. A total of 113 347 diabetic men and 131 573 diabetic women aged 25 years at recruitment from 1995 to 1998 were followed up until the end of 2006. Age/sex-specific colon cancer mortality rate ratios were calculated comparing the mortality rates of the diabetic patients with the average mortality rates of the general population within 12 years (1995-2006). A sub-cohort of diabetic patients (42 260 men and 49 405 women) was interviewed using a baseline questionnaire and Cox's regression was used to evaluate the risk factors for colon cancer mortality in these diabetic patients. RESULTS: The crude and age-standardized trends of colon cancer mortality from 1995 to 2006 increased significantly for both sexes in the general population. A total of 641 diabetic men and 573 diabetic women died of colon cancer, with a mortality rate of 74.4 and 54.3 per 100 000 person-years, respectively. Mortality rate ratios [95% confidence intervals (Cis)] showed a significantly higher risk of mortality from colon cancer for the diabetic patients compared to the general population, with the magnitude increasing with decreasing age: 1.65 (1.40-1.95), 2.01 (1.78-2.27), 2.75 (2.36-3.21) and 5.69 (4.65-6.96) for >= 75, 65-74, 55-64 and 25-54 years old, respectively, for men; and 1.46 (1.24-1.72), 2.09 (1.84-2.38), 2.67 (2.27-3.14) and 3.05 (2.29-4.06), respectively, for women. Among the sub-cohort of diabetic patients who had been interviewed with the baseline questionnaire, including information on age, sex, diabetes duration, diabetes type, body mass index, smoking, insulin use and area of residence, age and smoking were significantly predictive for colon cancer mortality, with respective adjusted hazard ratios (HRs) (95% CIs) of 1.077 (1.066-1.088) and 1.384 (1.068-1.792). Diabetes duration became a significant factor when those who died of colon cancer within 5 years of diabetes diagnosis were excluded to minimize the possible contamination of diabetes caused by incipient colon cancer, with an adjusted hazard ratio of 1.021 (1.007-1.034). Sex, diabetes type, insulin use, body mass index and area of residence were not significant predictors for colon cancer mortality in the diabetic patients. Although insulin use was categorized into subgroups of duration of use (non-users and users < 5 years, 5-9 years and >= 10 years), none of the HRs for colon cancer mortality was significant with regards to different durations of insulin use. CONCLUSION: Colon cancer mortality is increasing in Taiwan. A higher risk is observed in diabetic patients. Smoking, but not insulin use, is a modifiable risk factor. (C) 2012 Baishideng. All rights reserved.
引用
收藏
页码:4182 / 4190
页数:9
相关论文
共 50 条
  • [41] Insulin secretagogues were associated with increased mortality compared with metformin in type 2 diabetes
    Prutsky, Gabriela
    Domecq, Juan Pablo
    Tsapas, Apostolos
    ANNALS OF INTERNAL MEDICINE, 2012, 156 (02)
  • [42] Early-onset Type 2 diabetes is associated with higher risk of mortality: An analysis of the National Diabetes Audit
    Holman, N.
    Sattar, N.
    Wild, S.
    Khunti, K.
    Young, B.
    DIABETIC MEDICINE, 2018, 35 : 12 - 12
  • [43] Diabetes-associated angiotensin activation enhances liver metastasis of colon cancer
    Shimomoto, Takasumi
    Ohmori, Hitoshi
    Luo, Yi
    Chihara, Yoshitomo
    Denda, Ayumi
    Sasahira, Tomonori
    Tatsumoto, Naokuni
    Fujii, Kiyomu
    Kuniyasu, Hiroki
    CLINICAL & EXPERIMENTAL METASTASIS, 2012, 29 (08) : 915 - 925
  • [44] Obesity, insulin and chemoresistance in colon cancer
    Renehan, Andrew G.
    Dive, Caroline
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2011, 2 (01) : 8 - 10
  • [45] Diabetes-associated angiotensin activation enhances liver metastasis of colon cancer
    Takasumi Shimomoto
    Hitoshi Ohmori
    Yi Luo
    Yoshitomo Chihara
    Ayumi Denda
    Tomonori Sasahira
    Naokuni Tatsumoto
    Kiyomu Fujii
    Hiroki Kuniyasu
    Clinical & Experimental Metastasis, 2012, 29 : 915 - 925
  • [46] SEVERITY OF BREAST CANCER ASSOCIATED WITH TYPE 2 DIABETES AND NOT WITH INSULIN TREATMENT
    Overbeek, J. A.
    van Herk-Sukel, M. P.
    Vissers, P. A.
    van der Heijden, A. A.
    Bronsveld, H. K.
    Herings, R. M.
    Schmidt, M. K.
    Nijpels, G.
    VALUE IN HEALTH, 2018, 21 : S16 - S16
  • [47] Cancer Associated Thrombosis Is Associated with Higher Mortality across All Khorana Score Risk Levels
    Khorana, Alok A.
    McCrae, Keith R.
    Kuderer, Nicole M.
    Milentijevic, Dejan
    Laliberte, Francois
    Germain, Guillaume
    MacKnight, Sean D.
    Lefebvre, Patrick
    Lyman, Gary H.
    Streiff, Michael B.
    BLOOD, 2019, 134
  • [48] COLON CANCER MORTALITY AMONG AMPUTEES
    PAGE, WF
    NORMAN, JE
    HRUBEC, Z
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (02) : 154 - 155
  • [49] MORTALITY FACTORS IN CANCER OF COLON AND RECTUM
    GARB, JL
    DECONTI, RC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 384 - 384
  • [50] Cancer mortality and insulin glargine
    Bloomgarden, Zachary
    Handelsman, Yehuda
    JOURNAL OF DIABETES, 2009, 1 (03) : 131 - 133